BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

OJBio Ltd. Release: Latest Advances In Point Of Care Medical Diagnostics


11/12/2013 9:21:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

November 12, 2013 -- At this year’s Medica exhibition OJBio will be showcasing the latest developments in its biosensor platform technology for the rapid point of care diagnosis of infectious diseases.

The company, a joint venture between Orla Protein Technologies Ltd and Japan Radio Company Ltd (JRC), successfully combines specialist protein-based biosensor materials with advanced electronics to create innovative new biochip technology.

The biochips translate antibody-antigen binding events from samples into an electronic signal, successfully combining rapid disease diagnosis with inbuilt wireless connectivity.

At Medica 2013 OJ-Bio will be demonstrating the latest advances in this technology by showcasing its new ‘next generation’ results reading device for the accurate and rapid detection of common respiratory viruses, including the influenza A and B viruses and Respiratory Synctyial Virus (RSV).

The fully functional handheld pilot device has been developed for large-scale clinical trials for these disease markers, with the associated electronic storage and wireless transmission of results making it ideal for remote use and near-patient testing.

As well as respiratory diseases, OJ-Bio is currently involved in clinical development programmes for the point of care diagnosis of HIV and peridontal gum disease. In addition, existing immunoassays for other infectious diseases can be easily transferred to the OJ Bio platform giving it the potential for use in a wide pharmaceutical, animal health, environmental and consumer diagnostic applications.

The company’s advanced technology is now ready for final development into reliable and cost-effective point of care diagnostic sensors and approaches are welcome from organisations with an interest in partnering or licensing the technology.

Full details at www.oj-bio.com and www.jrc.co.jp

Issued on behalf of OJ-Bio by MHW PR. For more details please contact Ian Watson or Andy Bruce on 0191 233 1300 ian@mhwpr.co.uk

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES